Back to search
Anticancer Treatment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anticancer Treatment trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anticancer Treatment trials you may qualify forThis phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high…
Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors
This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once…
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of inlexisertib in combination with anticancer…
The objective of this observational study was to gain a deeper understanding of the epidemiology of the disease in Hungary through a broad analysis of patients…
This study aims to evaluate the safety and tolerability of RO7673396 in participants with advanced solid tumors harboring RAS mutation(s). This study consists o…
The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to identify the o…
The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to identify the…